Evidence map›Paper›PMID 23313378›Full record

ArticleToxicology2013

(-)-Xanthatin up-regulation of the GADD45γ tumor suppressor gene in MDA-MB-231 breast cancer cells: role of topoisomerase IIα inhibition and reactive oxygen species.

Shuso Takeda, Momoko Noguchi, Kazumasa Matsuo, Yasuhiro Yamaguchi, Taichi Kudo, Hajime Nishimura, Yoshiko Okamoto, Toshiaki Amamoto, Mitsuru Shindo, Curtis J Omiecinski and 1 more

Open access · greenAbstract read
In one paragraph

Article in Toxicology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Shuso TakedaDepartment of Molecular Biology, Daiichi University of Pharmacy, 22-1 Tamagawa-cho, Minami-ku, Fukuoka 815-8511, Japan.
Momoko Noguchi
Kazumasa Matsuo
Yasuhiro Yamaguchi
Taichi Kudo
Hajime Nishimura
Yoshiko Okamoto
Toshiaki Amamoto
Mitsuru Shindo
Curtis J Omiecinski
Hironori Aramaki
Daiichi University of Pharmacy · JPKyushu University · JPPennsylvania State University · US

Funding

Interindividual Variability in Human Microsomal Epoxide HydrolaseR01ES016358 · NIEHS · PENNSYLVANIA STATE UNIVERSITY, THE · PI OMIECINSKI, CURTIS J · 2009 to 2012
$1.3M
NIEHS NIH HHS ES016358NIEHS NIH HHS R01 ES016358
6 · The paper itself

Abstract

Previously, we reported that (-)-xanthatin, a naturally occurring xanthanolide present in the Cocklebur plant, exhibits potent anti-proliferative effects on human breast cancer cells, accompanied by an induction of the growth arrest and DNA damage-inducible gene 45γ (GADD45γ), recognized recently as a novel tumor suppressor gene. However, the mechanisms mediating this activation were unknown. Topoisomerase IIα (Topo IIα) inhibition has been reported to produce a cell death response accompanied by an atypical DNA laddering fragmentation profile, similar to that noted previously for (-)-xanthatin. Therefore we hypothesized that (-)-xanthatin's GADD45γ activation was mediated through the Topo IIα pathway. Here, we identify that (-)-xanthatin does function as a catalytic inhibitor of Topo IIα, promoting DNA damage. In addition, reactive oxygen species (ROS) were elevated in cells treated with this agent. Mechanistically, it was determined that the induced levels of GADD45γ mRNA resulting from (-)-xanthatin exposures were stabilized by coordinately produced ROS, and that the consequent induction of GADD45γ mRNA, GADD45γ protein and ROS generation were abrogated by co-treatment with N-acetyl-l-cysteine. Taken together, the data support the concept that Topo IIα inhibition by (-)-xanthatin is a trigger that stimulates expression of DNA damage-inducible GADD45γ mRNA and that concomitantly produced ROS act downstream to further enhance the GADD45γ mRNA/GADD45γ protein induction process, resulting in breast cancer cell death.

Indexed as

Topoisomerase II InhibitorsAcetylcysteineAntigens, NeoplasmBlotting, WesternCell Line, TumorDNA-Binding ProteinsDNA DamageDNA, NeoplasmDNA Topoisomerases, Type IIFemaleFree Radical ScavengersFuransGADD45 ProteinsGlutathioneHalf-LifeHumansAcetylcysteineAntigens, NeoplasmDNA-Binding ProteinsDNA, NeoplasmDNA Topoisomerases, Type IIFree Radical ScavengersFuransGADD45 ProteinsGlutathioneInsecticidesIntracellular Signaling Peptides and ProteinsReactive Oxygen SpeciesRNA, MessengerTopoisomerase II Inhibitorsxanthatin

Identifiers

PMID23313378
PMCPMC4030303
OpenAlexW2023866856

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.